Trials / Recruiting
RecruitingNCT06644222
Effectiveness of Airrosti and TheraBand Exercises on Double-Crossed Syndrome in Smart Phone User's Shoulder
The Effectiveness of Airrosti and TheraBand Exercises on Pain and Disability on Double-Crossed Syndrome in Smart Phone User's Shoulder
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Majmaah University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 25 Years
- Healthy volunteers
- Accepted
Summary
Double-crossed syndrome" refers to a specific alignment of overactive and underactive muscles in the neck, chest, and shoulders. AIRROSTI stands for Applied Integration for the Rapid Recovery of Soft Tissue Injuries. This study aims to evaluate the effectiveness of Airrosti exercises combined with TheraBand exercises in reducing pain and disability in the neck and shoulders. TheraBand exercise programs are commonly used to improve muscle activation. However, research on the effectiveness of AIRROSTI combined with TheraBand exercises for treating Double-Crossed Syndrome among smartphone users is limited, and more evidence is needed to support their effectiveness.
Detailed description
Research objective is to evaluate the effectiveness of Airrosti and Theraband exercises in reducing pain and disability among smartphone users with Double-Crossed Syndrome. To evaluate the combined effect of Airrosti and Theraband exercises in reducing pain and disability among smartphone users with Double-Crossed Syndrome. To compare the effect of Airrosti and Theraband exercises in reducing pain and disability among smartphone users with Double-Crossed Syndrome.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | AIRROSTI exercises | Group A will receive AIRROSTI exercises for 45 minutes / one session daily for five days per week |
| BEHAVIORAL | Thera band exercises | Group B will receive Thera band exercises for 45 minutes/one session per day for five days per week. |
Timeline
- Start date
- 2024-12-10
- Primary completion
- 2025-12-15
- Completion
- 2025-12-30
- First posted
- 2024-10-16
- Last updated
- 2025-05-20
Locations
1 site across 1 country: Saudi Arabia
Source: ClinicalTrials.gov record NCT06644222. Inclusion in this directory is not an endorsement.